ACCUSTEM SCIENCES, INC. Operating Cash Flow
ACCUSTEM SCIENCES, INC. (ACUT) reported Operating Cash Flow of -$623.03 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$248.85K, a 1253.85% decline year-over-year.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$374.18K.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $22.36K, a 5300.24% increase year-over-year.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$604.13K.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$850.39K.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$664.07K.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$1.62M.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$1.81M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$248.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$623.03K 10-Q · filed 2026-08-14 | -$600.67K derived: sum of 3 quarters · filed 2026-08-14 | -$1.20M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$374.18K 10-Q · filed 2026-05-15 | -$351.82K derived: sum of 2 quarters · filed 2026-05-15 | -$955.95K derived: sum of 3 quarters · filed 2026-05-15 | -$934.38K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $22.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$581.77K derived: sum of 2 quarters · filed 2026-04-14 | -$560.21K derived: sum of 3 quarters · filed 2026-08-14 | -$850.39K 10-K · filed 2026-04-14 | ||
| 2025-09-30 | -$604.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$582.56K derived: sum of 2 quarters · filed 2026-08-14 | -$872.75K 10-Q · filed 2025-11-12 | -$872.33K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $21.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$268.62K 10-Q · filed 2026-08-14 | -$268.20K derived: sum of 3 quarters · filed 2026-08-14 | -$486.15K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$290.18K 10-Q · filed 2026-05-15 | -$289.77K derived: sum of 2 quarters · filed 2026-05-15 | -$507.71K derived: sum of 3 quarters · filed 2026-05-15 | -$716.90K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $414.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$217.53K derived: sum of 2 quarters · filed 2026-04-14 | -$426.71K derived: sum of 3 quarters · filed 2026-04-14 | -$664.07K 10-K · filed 2026-04-14 | ||
| 2024-09-30 | -$217.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$427.13K derived: sum of 2 quarters · filed 2025-11-12 | -$664.48K 10-Q · filed 2025-11-12 | -$959.51K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$209.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$446.53K 10-Q · filed 2025-08-14 | -$741.56K derived: sum of 3 quarters · filed 2025-08-14 | -$1.09M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$237.35K 10-Q · filed 2025-05-20 | -$532.38K derived: sum of 2 quarters · filed 2025-05-20 | -$884.00K derived: sum of 3 quarters · filed 2025-05-20 | -$1.41M derived: sum of 4 quarters · filed 2025-05-20 | ||
| 2023-12-31 | -$295.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | -$646.64K derived: sum of 2 quarters · filed 2025-04-03 | -$1.17M derived: sum of 3 quarters · filed 2025-04-03 | -$1.62M 10-K · filed 2025-04-03 | ||
| 2023-09-30 | -$351.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | -$874.52K derived: sum of 2 quarters · filed 2024-11-18 | -$1.32M 10-Q · filed 2024-11-18 | -$1.94M derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2023-06-30 | -$522.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-16 | -$969.00K 10-Q · filed 2024-09-16 | -$1.59M derived: sum of 3 quarters · filed 2024-09-16 | -$2.15M derived: sum of 4 quarters · filed 2024-09-16 | ||
| 2023-03-31 | -$446.09K 10-Q · filed 2024-05-20 | -$1.07M derived: sum of 2 quarters · filed 2024-05-20 | -$1.62M derived: sum of 3 quarters · filed 2024-05-20 | -$2.62M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2022-12-31 | -$622.26K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$1.18M derived: sum of 2 quarters · filed 2024-03-22 | -$2.18M derived: sum of 3 quarters · filed 2024-03-22 | -$1.81M 10-K · filed 2024-03-22 | ||
| 2022-09-30 | -$555.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.56M derived: sum of 2 quarters · filed 2023-11-13 | -$1.18M 10-Q · filed 2023-11-13 | -$1.32M 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$628.51K 10-Q · filed 2023-08-14 | -$764.75K 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | $371.98K 10-Q · filed 2023-05-05 |